Effect of water fluoridation on the development of medial vascular calcification in uremic rats
Resumen: Public water fluoridation is a common policy for improving dental health. Fluoride replaces the hydroxyls of hydroxyapatite, thereby improving the strength of tooth enamel, but this process can also occur in other active calcifications. This paper studies the effects of water fluoridation during the course of vascular calcification in renal disease.
The effect of fluoride was studied in vitro and in vivo. Rat aortic smooth muscle cells were calcified with 2 mM Pi for 5 days. Fluoride concentrations of 5–10 μM – similar to those found in people who drink fluoridated water – partially prevented calcification, death, and osteogene expression in vitro. The anticalcifying mechanism was independent of cell activity, matrix Gla protein, and fetuin A expressions, and it exhibited an IC50 of 8.7 μM fluoride. In vivo, however, fluoridation of drinking water at 1.5 mg/L (concentration recommended by the WHO) and 15 mg/L dramatically increased the incipient aortic calcification observed in rats with experimental chronic kidney disease (CKD, 5/6-nephrectomy), fed a Pi-rich fodder (1.2% Pi). Fluoride further declined the remaining renal function of the CKD animals, an effect that most likely overwhelmed the positive effect of fluoride on calcification in vitro. Ultrastructural analysis revealed that fluoride did not modify the Ca/P atomic ratio, but it was incorporated into the lattice of in vivo deposits. Fluoride also converted the crystallization pattern from plate to rode-like structures.
In conclusion, while fluoride prevents calcification in vitro, the WHO's recommended concentrations in drinking water become nephrotoxic to CKD rats, thereby aggravating renal disease and making media vascular calcification significant.

Idioma: Inglés
DOI: 10.1016/j.tox.2014.01.012
Año: 2014
Publicado en: TOXICOLOGY 318 (2014), 40-50
ISSN: 0300-483X

Factor impacto JCR: 3.621 (2014)
Categ. JCR: TOXICOLOGY rank: 16 / 88 = 0.182 (2014) - Q1 - T1
Categ. JCR: PHARMACOLOGY & PHARMACY rank: 56 / 255 = 0.22 (2014) - Q1 - T1

Financiación: info:eu-repo/grantAgreement/ES/DGA/B008-09
Financiación: info:eu-repo/grantAgreement/ES/MINECO/MAT2011-259911
Financiación: info:eu-repo/grantAgreement/ES/MINECO/SAF2012-33898
Tipo y forma: Artículo (Versión definitiva)
Área (Departamento): Area Toxicología (Dpto. Anat.Pat.Med.Leg.For.To.)
Área (Departamento): Área Física Materia Condensada (Dpto. Física Materia Condensa.)


Derechos Reservados Derechos reservados por el editor de la revista


Exportado de SIDERAL (2025-11-27-15:23:38)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Artículos > Artículos por área > Física de la Materia Condensada
Artículos > Artículos por área > Toxicología



 Registro creado el 2025-11-13, última modificación el 2025-11-27


Versión publicada:
 PDF
Valore este documento:

Rate this document:
1
2
3
 
(Sin ninguna reseña)